Phenotype of de novo AML blasts prepared by BR density centrifugation
| . | All de novo AML cases . | M0 cases . | ||
|---|---|---|---|---|
| . | Number (%)5-150 . | Median, range5-151 . | Number5-150 . | Median, range5-151 . |
| CD2 | 2/47 (4.3) | 36, 34-39 | 0/3 | — |
| CD3 | 0/47 (0) | — | 0/3 | — |
| CD4 | 5/31 (16) | 26, 22-97 | 0/3 | — |
| CD5 | 2/47 (4.3) | 34, 22-46 | 0/3 | — |
| CD7 | 18/55 (32.7) | 65, 22-100 | 2/5 | 61, 22-100 |
| CD8 | 0/47 (0) | — | 0/3 | — |
| CD10 | 2/55 (3.6) | 23, 22-24 | 0/5 | — |
| CD11b | 9/31 (29.0) | 37, 20-95 | 0/3 | — |
| CD13 | 49/55 (89.1) | 85, 30-98 | 4/5 | 93, 92-96 |
| CD14 | 4/31 (12.9) | 33, 23-64 | 0/5 | — |
| CD15 | 20/47 (42.6) | 38, 20-83 | 1/3 | 42 |
| CD19 | 8/55 (14.5) | 32, 23-53 | 0/5 | — |
| CD20 | 0/47 (0) | — | 0/3 | — |
| CD33 | 49/55 (89.1) | 86, 22-100 | 3/5 | 57, 41-96 |
| CD34 | 26/55 (47.3) | 87, 50-99 | 4/5 | 85, 56-96 |
| CD38 | 9/14 (64.3) | 76, 39-99 | 2/2 | 83, 74-92 |
| CD56 | 11/31 (35.5) | 69, 31-99 | 1/3 | 31 |
| CD117 | 27/47 (57.4) | 37, 20-66 | 2/3 | 41, 20-61 |
| HLA-DR | 40/55 (72.7) | 91, 31-100 | 5/5 | 94, 74-97 |
| GPA | 0/31 (0) | — | 0/3 | — |
| . | All de novo AML cases . | M0 cases . | ||
|---|---|---|---|---|
| . | Number (%)5-150 . | Median, range5-151 . | Number5-150 . | Median, range5-151 . |
| CD2 | 2/47 (4.3) | 36, 34-39 | 0/3 | — |
| CD3 | 0/47 (0) | — | 0/3 | — |
| CD4 | 5/31 (16) | 26, 22-97 | 0/3 | — |
| CD5 | 2/47 (4.3) | 34, 22-46 | 0/3 | — |
| CD7 | 18/55 (32.7) | 65, 22-100 | 2/5 | 61, 22-100 |
| CD8 | 0/47 (0) | — | 0/3 | — |
| CD10 | 2/55 (3.6) | 23, 22-24 | 0/5 | — |
| CD11b | 9/31 (29.0) | 37, 20-95 | 0/3 | — |
| CD13 | 49/55 (89.1) | 85, 30-98 | 4/5 | 93, 92-96 |
| CD14 | 4/31 (12.9) | 33, 23-64 | 0/5 | — |
| CD15 | 20/47 (42.6) | 38, 20-83 | 1/3 | 42 |
| CD19 | 8/55 (14.5) | 32, 23-53 | 0/5 | — |
| CD20 | 0/47 (0) | — | 0/3 | — |
| CD33 | 49/55 (89.1) | 86, 22-100 | 3/5 | 57, 41-96 |
| CD34 | 26/55 (47.3) | 87, 50-99 | 4/5 | 85, 56-96 |
| CD38 | 9/14 (64.3) | 76, 39-99 | 2/2 | 83, 74-92 |
| CD56 | 11/31 (35.5) | 69, 31-99 | 1/3 | 31 |
| CD117 | 27/47 (57.4) | 37, 20-66 | 2/3 | 41, 20-61 |
| HLA-DR | 40/55 (72.7) | 91, 31-100 | 5/5 | 94, 74-97 |
| GPA | 0/31 (0) | — | 0/3 | — |
Data for all cases and M0 cases are shown. All cases include 5 M0, 13 M1, 18 M2, 9 M4, 7 M5, 1 M6, and 2 unclassified AML cases.
Positive number of cases/analyzed number of cases (positive cases %).
Median and range of the percentage of blasts expressing each antigen in the positive cases.